Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sprayable metal-phenolic network tailored antioxidant powder remodels endometrial oxidative-inflammatory homeostasis for chronic endometritis therapy and fertility restoration.

Created on 16 Oct 2026

Authors

Wangyan He, Jingkai Xie, Xiangyou Zheng, Ying Xu, Zi Ye, Daoyang Zhu, Liaobing Xin, Songying Zhang, Lie Ma

Published in

Biomaterials science. Oct 15, 2026. Epub Oct 15, 2026.

Abstract

Chronic endometritis (CE) is a persistent inflammatory disorder of the endometrium characterized by aberrant plasma cell infiltration and strongly associated with female infertility. CE pathogenesis is driven by persistent microbial stimulation, excessive reactive oxygen species (ROS) accumulation, and local immune dysregulation, whereas antibiotics and hysteroscopic surgery do not sufficiently resolve the sustained oxidative-inflammatory microenvironment. A sprayable antioxidant powder, RuO2@GelMA@TA-Fe3+ (RGTF), is developed for localized remodeling of endometrial oxidative-inflammatory homeostasis. A tannic acid-Fe3+ metal-phenolic network (MPN) serves as a functional interfacial layer, providing wet-tissue adhesion, prolonged local retention, and complementary free-radical scavenging, while embedded RuO2 nanozymes enable efficient ROS elimination. Optimized RGTF exhibits favorable sprayability, hydration-triggered tissue adhesion, and robust scavenging activity against hydrogen peroxide (H2O2) and multiple representative free radicals. In vitro, RGTF reduces intracellular ROS in H2O2-stimulated human endometrial stromal cells (HESCs) and promotes macrophage transition from a pro-inflammatory to a reparative phenotype. In a lipopolysaccharide (LPS)-induced rat CE model, local RGTF treatment alleviates oxidative damage and inflammation, promotes endometrial structural restoration, and rescues fertility-related dysfunction. This MPN-enabled platform provides a promising local strategy for CE intervention.

PMID:
42885500
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement